Certain Medicare plans typically cover at least part of the cost of inhalers for COPD. There are also several ways to further save on costs.

Tezepelumab did not significantly decrease moderate or severe COPD exacerbations compared with placebo, the COURSE trial found.

At the top of that list, unsurprisingly, are Novo Nordisk obesity drugs Ozempic, Rybelsus, and Wegovy, all grouped together ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Biden administration has announced the next 15 drugs chosen for Medicare negotiation, marking one of its final acts ...

Ozempic and Wegovy, Novo Nordisk’s GLP-1 drugs that treat diabetes and obesity, are on the list. Astellas Pharma’s prostate cancer drug, Xtandi, is also on the list — alongside AstraZeneca’s cancer ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

The Biden administration on Friday released its next round of prescription drugs selected for Medicare price negotiations, ...

The Centers for Medicare and Medicaid Services (CMS) had until Feb. 1 to release the list ... treated by these drugs include diabetes, cancer, chronic obstructive pulmonary disease (COPD) and ...

Novo Nordisk's Ozempic and Wegovy are among 15 drugs targeted for Medicare price negotiations in 2027. The U.S. aims to cut ...

“Every time a new list (of drugs) comes out ... Ofev, which treats idiopathic pulmonary fibrosis. • Linzess, which treats chronic idiopathic constipation and irritable bowel syndrome with ...